Evidence map›Paper›PMID 15466047›Full record

ArticleJournal of bacteriology2004

Genomic studies with Escherichia coli MelR protein: applications of chromatin immunoprecipitation and microarrays.

David C Grainger, Timothy W Overton, Nikos Reppas, Joseph T Wade, Eiji Tamai, Jon L Hobman, Chrystala Constantinidou, Kevin Struhl, George Church, Stephen J W Busby

Abstract read
In one paragraph

Article in Journal of bacteriology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Transcription of Bacterial Chromatin.Journal of molecular biology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David C GraingerSchool of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. d.grainger@bham.ac.uk.
Timothy W Overton
Nikos Reppas
Joseph T Wade
Eiji Tamai
Jon L Hobman
Chrystala Constantinidou
Kevin Struhl
George Church
Stephen J W Busby

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli MelR protein is a transcription activator that is essential for melibiose-dependent expression of the melAB genes. We have used chromatin immunoprecipitation to study the binding of MelR and RNA polymerase to the melAB promoter in vivo. Our results show that MelR is associated with promoter DNA, both in the absence and presence of the inducer melibiose. In contrast, RNA polymerase is recruited to the melAB promoter only in the presence of inducer. The MelR DK261 positive control mutant binds to the melAB promoter but cannot recruit RNA polymerase. Further analysis of immunoprecipitated DNA, by using an Affymetrix GeneChip array, showed that the melAB promoter is the major, if not the sole, target in E. coli for MelR. This was confirmed by a transcriptomics experiment to analyze RNA in cells either with or without melR.

Indexed as

Gene Expression Regulation, BacterialGenome, BacterialChromatinDNA-Binding ProteinsDNA-Directed RNA PolymerasesEscherichia coliEscherichia coli ProteinsGene Expression ProfilingMelibioseOligonucleotide Array Sequence AnalysisPrecipitin TestsPromoter Regions, GeneticProtein BindingSymportersTrans-ActivatorsChromatinDNA-Binding ProteinsDNA-Directed RNA PolymerasesEscherichia coli ProteinsMelibiosemelibiose permeaseMelR protein, E coliSymportersTrans-Activators

Identifiers

PMID15466047
PMCPMC522211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.